For #TrialTuesday, learn more about the JANUS trial (Alliance A022104) led by J. Josh Smith, MD, PhD, of Memorial Sloan Kettering Cancer Center. This trial aims to compare the effect of irinotecan versus oxaliplatin after long-course chemoradiation in patients with stage II-III #rectalcancer. Visit https://lnkd.in/gMK4_ibj #NCI #NCTN
Alliance for Clinical Trials in Oncology
Research Services
Chicago, IL 9,424 followers
Reducing the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines.
About us
The Alliance for Clinical Trials in Oncology is a national clinical trials network sponsored by the National Cancer Institute (NCI) that consists of nearly 10,000 cancer specialists at hospitals, medical centers, and community clinics across the United States and Canada. The Alliance is dedicated to developing and conducting clinical trials with promising new cancer therapies, and utilizes the best science to develop optimal treatment and prevention strategies for cancer, as well as researching methods to alleviate side effects of cancer and cancer treatments. The Alliance is a member of the NCI National Clinical Trials Network (NCTN) and also serves as a research base for the NCI Community Research Oncology Program (NCORP). The Alliance seeks to reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines, committed to discovering, validating and disseminating effective strategies for the prevention and treatment of cancer. Our mission is three-fold: To conduct high quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network; To further our understanding of the biological basis of the cancer process and its treatment, from discovery, to validation, to clinical practice; and To provide a scientific and operational infrastructure for innovative clinical and translational research in the academic and community settings.
- Website
-
http://www.AllianceNCTN.org
External link for Alliance for Clinical Trials in Oncology
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- Chicago, IL
- Type
- Nonprofit
- Founded
- 2011
- Specialties
- Cancer Research , Cancer Control, Cancer Prevention , Cancer Treatment, Research Network, Clinical Practice, Clinical Research, Translational Research , and Clinical Trials
Locations
-
Primary
Get directions
125 S. Wacker Drive, Suite 1600,
Chicago, IL 60606, US
-
Get directions
221 Longwood Avenue, Room 108
Boston, MA 02115, US
Employees at Alliance for Clinical Trials in Oncology
-
Lisa Pitler
Healthcare Compliance Professional | Healthcare Regulatory Attorney | Research & Research Administration
-
Trinidad Ajazi
Chief Operating Officer
-
Stacy Reeves (Rogers), MBA, MPH
Clinical Research Operations
-
Lisa Mickolayck, MPH
Senior Translational Research Program Coordinator
Updates
-
ALCHEMIST trials are a group of studies seeking to improve treatment of patients with early stage non-small cell #lungcancer (NSCLC) whose tumors have been completely removed by surgery. Learn more about Alliance A151216 and A081801, visit https://bit.ly/ALCHEMIST24 #NCI #NCTN
-
-
#DYK: Dr. Neha Mehta-Shah, of Washington University in St. Louis, leads the Alliance A051902 trial to see how duvelisib and usual chemotherapy of cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone work to treat patients with peripheral T-cell #lymphoma: https://lnkd.in/dDAbUsv #NCI #NCTN #LYMsm
-
-
For #TrialTuesday, Dr. Andrew Ko, of UCSF Helen Diller Comprehensive Cancer Center, leads the Alliance A022106/PLATINUM trial to compare two chemotherapy regimens to treat patients with metastatic pancreatic cancer and BRCA1/2 or PALB2 gene mutation. To learn more about the PLATINUM trial, visit https://lnkd.in/gq9nYKxM #NCI #NCTN #PancChat #PancSM #CCDR
-
-
It's a wrap on an exciting four-day meeting! THANK YOU to everyone participating in the 2024 Alliance Spring Hybrid Group Meeting. Your remarkable efforts continue to advance cancer research. See you again in the fall - October 30-November 2. Stay well! #AllianceSpring24 #NCI #NCTN #NCORP
-
-
Welcome to Day 4 – Learn about myeloMATCH MSRP: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study. Sessions on this master screening and reassessment protocol start at 9a CT and 10a CT. #AllianceSpring24 #NCI #NCTN
-
-
Hats off to the amazing Alliance Patient Advocate Committee led by Patty Spears, Vernal Branch and Jane Perlmutter! #AllianceSpring24 #NCI #NCTN #NCORP #CancerResearch #patientadvocacy
-
-
Congratulations to Marie Wood MD (University of Colorado), Aminah Jatoi, MD (Mayo Clinic), Lucile Adams-Campbell, PhD (Georgetown University), John Leonard, MD (NYP/Weill Cornell Medical Center), Niveditha Subbiah, LLM, MA (Alliance Cancer Control Program), Jill Oliveri, DrPH (The Ohio State University) for receiving the Alliance for Clinical Trials in Oncology Foundation Special Projects Allocation Award. #AllianceSpring24 #NCI #NCTN #NCORP #CancerResearch
-
-
Congratulations to Frederick Howard, MD (University of Chicago), Alexander T. Pearson, MD, PhD (University of Chicago), Dezheng Huo, MD, PhD (University of Chicago), Rita Nanda, MD (University of Chicago), Charles Perou, PhD (University of North Carolina) and Galina Khramtsova, MD, PhD (University of Chicago) for receiving the Alliance for Clinical Trials in Oncology Foundation Special Projects Allocation Award. #AllianceSpring24 #NCI #NCTN #NCORP #CancerResearch
-
-
Congratulations to Kinsey Pebley, PhD, MPH, of Medical University of South Carolina, and Mentor: Alana Rojewski, PhD, for receiving the Alliance Cancer Control Program Pilot Project Award! Dr. Pebley's project title is “Video Interventions for Dependence on Smoke (VIDeOS) for Cancer Patients Prevention and Health Outcomes Committees” #AllianceSpring24 #NCI #NCORP #CancerResearch
-